Researchers from University of Aberdeen in the UK found found that a higher proportion of omega-3 metabolising enzyme to omega-6 metabolising enzyme is associated with less spread of the tumour and a greater chance of survival for an individual patient.
Omega-3 and omega-6 fatty acids are polyunsaturated fats that are thought to have opposing effects on health.
Researchers looked specifically at the enzymes responsible for breaking down omega-3 and omega-6 fatty acids and their relationship with survival in bowel cancer.
The molecules or 'metabolites' that arise from the breakdown of omega-3 - prevent tumour spread.
"We assume that with more of the enzyme that breaks down omega-3 there will be increased metabolites of omega-3, and this will limit tumour spread," researchers said.
"The less a tumour has spread the better the outcome. The converse is true for omega-6 metabolising enzyme - such that a higher proportion of omega-6 metabolising enzyme compared to omega-3 could lead to a worse outcome for the patient," Murray said.
The study was published in the British Journal of Cancer.
Disclaimer: No Business Standard Journalist was involved in creation of this content
